title: Efficacy and tolerability of zidovudine 200 mg twice a day as part of combination antiretroviral therapy for 96 weeks.
authors.forename: Chris
authors.initials: C
authors.lastname: Duncombe
authors.forename: Stephen J
authors.initials: SJ
authors.lastname: Kerr
authors.forename: John
authors.initials: J
authors.lastname: Liddy
authors.forename: Anchalee
authors.initials: A
authors.lastname: Avihingsanon
authors.forename: Kiat
authors.initials: K
authors.lastname: Ruxrungtham
authors.forename: Praphan
authors.initials: P
authors.lastname: Phanuphak
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D023241:Antiretroviral Therapy, Highly Active / Q000379:methods*; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D055118:Medication Adherence; D013997:Time Factors; D016896:Treatment Outcome; D015215:Zidovudine / Q000008:administration & dosage* / Q000009:adverse effects*
chemical_list: D019380:Anti-HIV Agents; D015215:Zidovudine